Free Trial
NASDAQ:PNTG

The Pennant Group (PNTG) Stock Price, News & Analysis

The Pennant Group logo
$26.13 -0.07 (-0.27%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$26.13 0.00 (0.00%)
As of 04/17/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About The Pennant Group Stock (NASDAQ:PNTG)

Key Stats

Today's Range
$25.66
$26.30
50-Day Range
$22.21
$26.98
52-Week Range
$19.64
$37.13
Volume
224,261 shs
Average Volume
225,013 shs
Market Capitalization
$907.29 million
P/E Ratio
38.43
Dividend Yield
N/A
Price Target
$34.80
Consensus Rating
Moderate Buy

Company Overview

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

The Pennant Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

PNTG MarketRank™: 

The Pennant Group scored higher than 66% of companies evaluated by MarketBeat, and ranked 317th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    The Pennant Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    The Pennant Group has only been the subject of 2 research reports in the past 90 days.

  • Read more about The Pennant Group's stock forecast and price target.
  • Earnings Growth

    Earnings for The Pennant Group are expected to grow by 17.33% in the coming year, from $0.75 to $0.88 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of The Pennant Group is 38.43, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.38.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of The Pennant Group is 38.43, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.84.

  • Price to Earnings Growth Ratio

    The Pennant Group has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    The Pennant Group has a P/B Ratio of 5.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about The Pennant Group's valuation and earnings.
  • Percentage of Shares Shorted

    1.81% of the float of The Pennant Group has been sold short.
  • Short Interest Ratio / Days to Cover

    The Pennant Group has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in The Pennant Group has recently increased by 0.21%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    The Pennant Group does not currently pay a dividend.

  • Dividend Growth

    The Pennant Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.81% of the float of The Pennant Group has been sold short.
  • Short Interest Ratio / Days to Cover

    The Pennant Group has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in The Pennant Group has recently increased by 0.21%, indicating that investor sentiment is decreasing.
  • News Sentiment

    The Pennant Group has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for The Pennant Group this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, The Pennant Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $18,540.00 in company stock.

  • Percentage Held by Insiders

    Only 5.80% of the stock of The Pennant Group is held by insiders.

  • Percentage Held by Institutions

    85.88% of the stock of The Pennant Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about The Pennant Group's insider trading history.
Receive PNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for The Pennant Group and its competitors with MarketBeat's FREE daily newsletter.

PNTG Stock News Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Wells Fargo Remains a Hold on Pennant Group (PNTG)
See More Headlines

PNTG Stock Analysis - Frequently Asked Questions

The Pennant Group's stock was trading at $26.52 on January 1st, 2025. Since then, PNTG stock has decreased by 1.5% and is now trading at $26.13.
View the best growth stocks for 2025 here
.

The Pennant Group, Inc. (NASDAQ:PNTG) announced its earnings results on Wednesday, February, 28th. The company reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by $0.01. The firm had revenue of $145.95 million for the quarter, compared to analysts' expectations of $136.79 million. The Pennant Group had a net margin of 3.24% and a trailing twelve-month return on equity of 13.47%.
Read the conference call transcript
.

The Pennant Group's top institutional investors include Rhumbline Advisers (0.14%), SG Americas Securities LLC (0.07%), Kings Path Partners LLC (0.03%) and GAMMA Investing LLC (0.02%). Insiders that own company stock include John G Nackel, Brent Guerisoli, John J Gochnour, Jennifer Freeman and Joanne Stringfield.
View institutional ownership trends
.

Shares of PNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that The Pennant Group investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), ServiceNow (NOW), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

Last Earnings
2/28/2024
Today
4/18/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PNTG
Fax
N/A
Employees
5,340
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$34.80
High Stock Price Target
$38.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+33.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
38.43
Forward P/E Ratio
34.84
P/E Growth
2.24
Net Income
$13.38 million
Pretax Margin
4.46%

Debt

Sales & Book Value

Annual Sales
$695.24 million
Cash Flow
$0.79 per share
Price / Cash Flow
32.92
Book Value
$4.86 per share
Price / Book
5.38

Miscellaneous

Free Float
32,356,000
Market Cap
$907.29 million
Optionable
Optionable
Beta
1.73
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PNTG) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners